Canada markets close in 1 hour 34 minutes

NeuPath Health Inc. (NPTH.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.19000.0000 (0.00%)
As of 02:12PM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 10.71M
Enterprise Value 19.52M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.16
Price/Book (mrq)0.49
Enterprise Value/Revenue 0.28
Enterprise Value/EBITDA 5.23

Trading Information

Stock Price History

Beta (5Y Monthly) 0.84
52-Week Change 38.57%
S&P500 52-Week Change 322.62%
52 Week High 30.2500
52 Week Low 30.1400
50-Day Moving Average 30.1837
200-Day Moving Average 30.1820

Share Statistics

Avg Vol (3 month) 352.89k
Avg Vol (10 day) 333.77k
Shares Outstanding 556.39M
Implied Shares Outstanding 656.29M
Float 848.2M
% Held by Insiders 10.98%
% Held by Institutions 124.24%
Shares Short (Aug 30, 2024) 418.26k
Short Ratio (Aug 30, 2024) 40.21
Short % of Float (Aug 30, 2024) 4N/A
Short % of Shares Outstanding (Aug 30, 2024) 40.03%
Shares Short (prior month Jul 15, 2024) 41.44k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jul 06, 2020
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin -0.11%
Operating Margin (ttm)3.91%

Management Effectiveness

Return on Assets (ttm)1.46%
Return on Equity (ttm)0.03%

Income Statement

Revenue (ttm)69.26M
Revenue Per Share (ttm)1.23
Quarterly Revenue Growth (yoy)10.10%
Gross Profit (ttm)N/A
EBITDA 2.07M
Net Income Avi to Common (ttm)-74k
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)284.40%

Balance Sheet

Total Cash (mrq)2.88M
Total Cash Per Share (mrq)0.05
Total Debt (mrq)11.69M
Total Debt/Equity (mrq)53.31%
Current Ratio (mrq)1.03
Book Value Per Share (mrq)0.39

Cash Flow Statement

Operating Cash Flow (ttm)2.52M
Levered Free Cash Flow (ttm)3.09M